The US Food and Drug Administration approves the first flu vaccine made from recombinant proteins rather than a weakened virus.
The Scientist
Most Recent
Just 3 days after five people involved in the polio vaccine effort in Pakistan were shot by unidentified assailants, three more are killed.
Five workers at anti-polio campaigns were shot at close range this week, creating a major setback for efforts to prevent the crippling disease.
By tapping local knowledge among African pastoralists and veterinarians, researchers successfully eradicated a deadly livestock virus—and are looking to replicate their success to halt other epidemics.
A handful of US states are enacting laws that make it harder for parents to opt out of vaccinating their children against infectious diseases.
Check out other memorable images and videos that were submitted to this year’s Labby Multimedia Awards.
Many vaccines are on the market for various serogroups of meningococcal disease, but a solution to provide broad protection against MenB remains elusive.
Two employees of the World Health Organization were shot last week while working on a vaccination campaign in Pakistan.
How the bacteria found in a tuberculosis vaccine can improve the outcome of bladder cancer treatment
Herd immunity, or the protection of individuals who are not vaccinated due to generally high vaccination rates within a population, does not currently exist in many pockets of the US.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
